
Trump scolds pharma execs, demanding lower prices, more US manufacturing while promising to slash FDA regs
Some of the top CEOs of the pharma industry got together with President Trump Tuesday morning looking for common ground. Instead, they got another lecture on drug pricing, a renewed promise that the FDA will speed up new drug approvals with just a fraction of the old regulations in play, and assurances of an FDA pick waiting in the wings who will help put everything in order.
“We have to get the prices way down,” said Trump, flanked by Celgene CEO Bob Hugin and Merck CEO Ken Frazier. “The pricing has been astronomical for our country.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.